Blood test could spot colon cancer early – 12,000 volunteers needed
NCT ID NCT06059963
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new blood test called Signal-C that looks for DNA fragments in the blood to detect colorectal cancer and advanced precancerous growths. Researchers will enroll 12,000 people aged 45-84 who are at average risk and already scheduled for a routine screening colonoscopy. The goal is to see how accurate the blood test is compared to the colonoscopy results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gastroenterology Consultants of SW Virginia
RECRUITINGRaonoke, Virginia, 24014, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?